Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 8, pp. 1-13
Open Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

The importance of exosomal PDL1 in tumour immune evasion
Dhouha Daassi, Kathleen M. Mahoney, Gordon J. Freeman
Nature reviews. Immunology (2020) Vol. 20, Iss. 4, pp. 209-215
Closed Access | Times Cited: 490
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
Pengfei Zhang, Chao Gao, Xiaoyong Huang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 463
Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 316
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 299
The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie, Mengxue Xu, Jian Lu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 293
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
Zongqiang Hu, Gang Chen, Yingpeng Zhao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 175
Exosomes as mediators of immune regulation and immunotherapy in cancer
Fernanda G. Kugeratski, Raghu Kalluri
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 10-35
Open Access | Times Cited: 158
The cutting-edge progress of immune-checkpoint blockade in lung cancer
Fei Zhou, Meng Qiao, Caicun Zhou
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 2, pp. 279-293
Open Access | Times Cited: 158
The crosstalk: exosomes and lipid metabolism
Wei Wang, Neng Zhu, Tao Yan, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 153
Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms
Chunyang Jiang, Na Zhang, Xiaoli Hu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 134
The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Shimin Xie, Zhengguo Wu, Yi Qi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111450-111450
Open Access | Times Cited: 120
Exosomes based strategies for brain drug delivery
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 120
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin, Min Yu, Tingting Ma, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001698-e001698
Open Access | Times Cited: 114
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 104
Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
Mengke Niu, Yiming Liu, Ming Yi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Wei Zhang, Wenqun Zhong, Beike Wang, et al.
Developmental Cell (2022) Vol. 57, Iss. 3, pp. 329-343.e7
Open Access | Times Cited: 93
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Extracellular vesicles and particles impact the systemic landscape of cancer
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 78
Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment
S. Rahimian, Hossein Najafi, Baran Afzali, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 123-123
Open Access | Times Cited: 29
Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Exosomes in Cancer: Diagnostic and Therapeutic Applications
Quratulain Maqsood, Aleena Sumrin, Yasar Saleem, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 17
Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy
Samantha M. Morrissey, Jun Yan
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 550-558
Open Access | Times Cited: 136
Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform
Alin Rai, Haoyun Fang, Bethany Claridge, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 97
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 92
Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4
Dong Ha Kim, Sojung Park, HyeongRyul Kim, et al.
Cancer Letters (2020) Vol. 475, pp. 2-13
Closed Access | Times Cited: 90
Page 1 - Next Page

Scroll to top